Showing 1 - 8 results of 8 for search 'R. Rifkin', query time: 0.03s
Refine Results
-
1
The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus. by Christophe Richez, Rocco J Richards, Pierre Duffau, Zachary Weitzner, Christopher D Andry, Ian R Rifkin, Tamar Aprahamian
Published 2013-01-01
Article -
2
Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2. by Kei Yasuda, Amanda A Watkins, Guneet S Kochar, Gabriella E Wilson, Bari Laskow, Christophe Richez, Ramon G Bonegio, Ian R Rifkin
Published 2014-01-01
Article -
3
Gene expression during the generation and activation of mouse neutrophils: implication of novel functional and regulatory pathways. by Jeffrey A Ericson, Pierre Duffau, Kei Yasuda, Adriana Ortiz-Lopez, Katherine Rothamel, Ian R Rifkin, Paul A Monach, ImmGen Consortium
Published 2014-01-01
Article -
4
Monoallelic IRF5 deficiency in B cells prevents murine lupus by Alex Pellerin, Kei Yasuda, Abraham Cohen-Bucay, Vanessa Sandra, Prachi Shukla, Barry K. Horne Jr, Kerstin Nündel, Gregory A. Viglianti, Yao Xie, Ulf Klein, Ying Tan, Ramon G. Bonegio, Ian R. Rifkin
Published 2021-08-01
Article -
5
Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via... by Rachel R. Yuen, Dylan Steiner, Riley M.F. Pihl, Elizabeth Chavez, Alex Olson, Erika L. Smith, Lillia A. Baird, Filiz Korkmaz, Patricia Urick, Manish Sagar, Manish Sagar, Manish Sagar, Jacob L. Berrigan, Suryaram Gummuluru, Ronald B. Corley, Ronald B. Corley, Karen Quillen, Anna C. Belkina, Anna C. Belkina, Gustavo Mostoslavsky, Ian R. Rifkin, Ian R. Rifkin, Yachana Kataria, Amedeo J. Cappione, Wenda Gao, Nina H. Lin, Nahid Bhadelia, Nahid Bhadelia, Jennifer E. Snyder-Cappione
Published 2021-04-01
Article -
6
PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by B. Paul, M. Liedtke, D. S. Siegel, J. Khouri, J. Hillenglass, R. Rifkin, M. D. Gandhi, A. Kin, M. Y. Levy, A. Mohrbacher, W. Schmidt, R. Silbermann, F. Cottini, D. W. Sborov, R. Walker, M. Murphy, L. Gu, A. Chen, N. Rajakumaraswamy, S. Z. Usmani
Published 2022-06-01
Article -
7
Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses by Jihyung Lee, Junyan Zhang, Young-Jun Chung, Jun Hwan Kim, Chae Min Kook, José M González-Navajas, David S Herdman, Bernd Nürnberg, Paul A Insel, Maripat Corr, Ji-Hun Mo, Ailin Tao, Kei Yasuda, Ian R Rifkin, David H Broide, Roger Sciammas, Nicholas JG Webster, Eyal Raz
Published 2020-02-01
Article -
8
P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN? by R Popat, A Badros, S Kumar, P Rodriguez-Otero, A Cohen, S Manier, P Voorhees, F Gay, R Rifkin, T Martin, A Chari, K Weisel, A Farooq, B Jeng, W Chng, H Lee, J Berdeja, V Jadhav, A Tosolini, L Eliason, A Palumbo, M Dimopoulos, S Lonial, S Trudel, P Richardson, E Terpos
Published 2022-04-01
Article